Fresenius | FRE - Current Assets


Fresenius reported EUR12.29B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Akzo Nobel EUR 8.41B 287M Sep/2026
Alcon AG USD 6.62B 4M Jun/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
BASF EUR 35.21B 3.58B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Beiersdorf EUR 7.43B 768M Jun/2026
DaVita Healthcare Partners USD 4.07B 114.82M Sep/2026
Demant DKK 10.2B 130M Jun/2026
E.ON EUR 28.7B 1.95B Sep/2026
Essilor EUR 11.24B 770M Jun/2026
Fresenius EUR 12.29B 678M Sep/2026
Fresenius Medical Care EUR 7.84B 150.6M Sep/2026
Getinge SEK 15.77B 2.39B Jun/2026
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.9B 336M Sep/2026
GN Store Nord DKK 20.15B 14.52B Sep/2026
GRIFOLS EUR 5.35B 40M Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 15.14B 1.37B Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Philips EUR 10.51B 1.18B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
RWE EUR 51.76B 10.21B Sep/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Smith & Nephew USD 4.39B 240M Jun/2026